Product Information
TIMOLOL 0.25% GEL-SOLUTION is a generic product labeled by Bausch & Lomb Americas Inc., priced at $6.9868 per ML under NDC 82260081825. Its NADAC has been published 123 times since Apr 17, 2024.
FDA first approved this application on Nov 4, 1993. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Timolol Maleate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
2.5 mg/mL
Manufacturer
Bausch & Lomb Americas Inc.NDC
82260081825
Classification
Generic
Dosage Form
SOLUTION
Route
OPHTHALMIC
Effective Date
8/19/2026
Active Ingredients
TIMOLOL MALEATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA020330FDA Approved
11/4/1993
TE Code
AB
On Market Since
2/14/2018
Pharmacological Classes
Price Statistics
The NADAC for TIMOLOL 0.25% GEL-SOLUTION has been published 123 times since Apr 17, 2024, and over the history we have for it it has declined 78.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.9868 per ML |
|---|---|
| All-time high | $32.2814 (May 15, 2024) |
| All-time low | $6.9868 (Aug 19, 2026) |
| 52-week high | $18.7032 |
| 52-week low | $6.9868 |
| Median price | $18.7032 |
| Average price | $19.2838 |
| Largest weekly change | -30.7% (May 22, 2024) |
| Weeks tracked | 123 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 92% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TIMOLOL 0.25% GEL-SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for TIMOLOL 0.25% GEL-SOLUTION, manufactured by Bausch & Lomb Americas Inc., is $6.9868 per ML (NDC 82260081825), effective Aug 19, 2026.
How has the price of TIMOLOL 0.25% GEL-SOLUTION changed over time?
Over the history we have for it, the NADAC for TIMOLOL 0.25% GEL-SOLUTION has declined 78.4%. It has been tracked across 123 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for TIMOLOL 0.25% GEL-SOLUTION?
Since Apr 17, 2024, the NADAC for TIMOLOL 0.25% GEL-SOLUTION has ranged from a low of $6.9868 (Aug 19, 2026) to a high of $32.2814 (May 15, 2024), with a median of $18.7032 per ML.
Are there cheaper alternatives to TIMOLOL 0.25% GEL-SOLUTION?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TIMOLOL MALEATE 0.25% EYE DROP, is $0.5843 per ML — about 92% below TIMOLOL 0.25% GEL-SOLUTION.
Who manufactures TIMOLOL 0.25% GEL-SOLUTION?
TIMOLOL 0.25% GEL-SOLUTION (NDC 82260081825) is labeled by Bausch & Lomb Americas Inc., and CMS classifies it as a generic product.